| Date | Title | Description |
| 14.09.2024 | The Intersection of Health and Innovation: A Weekly Snapshot | In the fast-paced world of healthcare, news can feel like a tidal wave. Each week, a multitude of press releases flood the media landscape, highlighting breakthroughs, initiatives, and pressing issues. This week is no different. From advanc... |
| 13.09.2024 | Weekly Recap: 12 Health Press Releases You Might Have Missed | A roundup of the most newsworthy healthcare press releases from PR Newswire this week, including Children's Growth Awareness Week, the effects of climate change on health and new innovations in AI health diagnostics.
NEW YORK, Sept. 13, 202... |
| 12.09.2024 | Moderna expects up to $3.5 billion in 2025 sales | Healthcare & PharmaceuticalsCommercial Strategy
Public Health
Moderna expects up to $3.5 billion in 2025 sales
By Patrick WingroveSeptember 12, 202410:15 AM UTCUpdated ago
Text
Small Text
Medium Text
Large Text
Share
X
Facebook
Linkedin... |
| 11.09.2024 | New NPG Forum Paper Warns of Potential Pandemic Threat and Examines the Population Factor | Explore the critical connection between population growth and the spread of infectious diseases in the latest NPG Forum paper
ALEXANDRIA, Va., Sept. 11, 2024 /PRNewswire-PRWeb/ -- Negative Population Growth, Inc. (NPG) proudly announces the... |
| 10.09.2024 | Health | When should I get flu and COVID shots? Experts disagree — but say get them however you can | Ideally, people would get their shots around late October, since the flu typically takes off in the state near the end of the year, Guthmiller said.
Not everyone agrees that waiting is the best plan.
While some people like to time their sho... |
| 09.09.2024 | Navigating the AI Tsunami: Strategies for Business Survival | The AI revolution is not a distant threat; it’s a current reality. Like a tsunami, it crashes over industries, reshaping landscapes and redefining norms. The question is not if AI will disrupt your business, but how you will adapt to its re... |
| 09.09.2024 | FAST COMPANY PRESENTS ITS 10th ANNUAL INNOVATION FESTIVAL | FastCompany.com
Fast Company will host its 10th annual Fast Company Innovation Festival September 16–19 in New York City featuring leaders, thinkers, and entrepreneurs who are shaping our future.
NEW YORK, Sept. 9, 2024 /PRNewswire-PRWeb/ -... |
| 08.09.2024 | MRNA Investors Have Opportunity to Lead Moderna, Inc. Securities Fraud Lawsuit | NEW YORK, Sept. 8, 2024 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Moderna, Inc. (NASDAQ: MRNA) between January 18, 2023 an... |
| 05.09.2024 | Don't Let AI Eat You Alive — Follow These 3 Strategies Instead Don't fear the rise of AI — instead, harness its power to create a more efficient, effective and ultimately successful business landscape... | The AI revolution isn't coming — it's already here, and it's moving faster than anyone imagined.
According to a 2024 McKinsey report, industries like professional services are racing to adopt AI, transforming workflows, streamlining process... |
| 05.09.2024 | OpenAI says it reached 1 million business users | Join our daily and weekly newsletters for the latest updates and exclusive content on industry-leading AI coverage. Learn More
OpenAI’s paid business offerings reached a milestone, reaching one million paying business users across ChatGPT E... |
| 31.08.2024 | CARsgen Therapeutics: A New Dawn in CAR T-Cell Therapy | In the bustling landscape of biopharmaceuticals, CARsgen Therapeutics Holdings Limited stands out like a lighthouse in a storm. Based in Shanghai, this company is pioneering innovative CAR T-cell therapies aimed at tackling some of the most... |
| 30.08.2024 | MRNA Investors Have Opportunity to Lead Moderna, Inc. Securities Fraud Lawsuit | NEW YORK, Aug. 30, 2024 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Moderna, Inc. (NASDAQ: MRNA) between January 18, 2023 an... |
| 30.08.2024 | FDA Authorizes Updated Novavax COVID-19 Vaccine to Better Protect Against Currently Circulating Variants | SILVER SPRING, Md., Aug. 30, 2024 /PRNewswire/ -- Today, the U.S. Food and Drug Administration granted emergency use authorization (EUA) for an updated version of the Novavax COVID-19 vaccine that more closely targets currently circulating ... |
| 29.08.2024 | Navigating the New Normal: COVID Vaccines and Creative Leadership in Healthcare | The landscape of healthcare marketing is shifting. Imre, a prominent brand engagement agency, has made significant strides by appointing Tracy Zuto and Malia Baker as key creative leaders. Their arrival signals a commitment to innovative, i... |
| 29.08.2024 | CARsgen® Announces 2024 Interim Results | SHANGHAI, Aug. 29, 2024 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, has announced its 2024... |
| 29.08.2024 | CARsgen® Announces 2024 Interim Results | SHANGHAI, Aug. 29, 2024 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, has announced its 2024... |
| 28.08.2024 | Moderna's Dual Edge: Legal Troubles and Vaccine Updates | In the world of biotechnology, the line between innovation and controversy is often razor-thin. Moderna, Inc. finds itself at this crossroads, facing a class action lawsuit while simultaneously rolling out updated COVID-19 vaccines. This du... |
| 28.08.2024 | Flagship Pioneering and Quotient Therapeutics Announce Agreement to Identify Potential Novel Targets for the Treatment of Cardiovascular and Renal Diseases under Strategic Partnership with Pfizer | Collaboration leverages Quotient's platform to identify somatic mutations in genes that modify the progression of cardiovascular and renal diseases
Quotient and Pioneering Medicines, Flagship's in-house drug development unit, will jointly c... |
| 27.08.2024 | Health | The new COVID vaccine is out. Why you might not want to rush to get it. | The Centers for Disease Control and Prevention now looks to wastewater as fewer people are reporting test results to health authorities. The wastewater data shows the epidemic is worst in Western and Southern states. In New York, for exampl... |
| 23.08.2024 | MRNA Investors Have Opportunity to Lead Moderna, Inc. Securities Fraud Lawsuit | NEW YORK, Aug. 23, 2024 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Moderna, Inc. (NASDAQ: MRNA) between January 18, 2023 an... |
| 22.08.2024 | FDA Approves and Authorizes Updated mRNA COVID-19 Vaccines to Better Protect Against Currently Circulating Variants | SILVER SPRING, Md., Aug. 22, 2024 /PRNewswire/ -- Today, the U.S. Food and Drug Administration approved and granted emergency use authorization (EUA) for updated mRNA COVID-19 vaccines (2024-2025 formula) to include a monovalent (single) co... |
| 06.08.2024 | Flagship Pioneering Announces Appointment of Raj Panjabi as Senior Partner | Former White House Top Health Security Official to Lead Flagship's Preemptive Health and Medicine Initiative
CAMBRIDGE, Mass., Aug. 6, 2024 /PRNewswire/ -- Flagship Pioneering, the bioplatform innovation company, today announced that global... |
| 06.08.2024 | Abnormal Security raises $250M on $5.1B valuation to enhance AI-driven cyber protection
Your vote of support is important to us and it helps us keep the content FREE.
One click below supports our miss... | Artificial intelligence-native human behavior security company Abnormal Security Corp. announced today that it has raised $250 million in late-stage funding on a $5.1 billion valuation.
The funding is intended to enable the company to conti... |
| 02.08.2024 | Fast Company Unveils List of the 10 Most Innovative People of the Last 10 Years | .
Ryan Reynolds, Lin-Manuel Miranda, Satya Nadella, Lina Khan, Sara Nelson, Ted Sarandos, José Andrés, Issa Rae, Jennifer Doudna, and Pat McGrath
will be featured speakers at the 10th annual Fast Company Innovation Festival
NEW YORK, Aug. 2... |
| 02.08.2024 | Singapore to merge EDBI, SEEDS Capital to form SG Growth Capital | Singapore will merge two state-backed investment agencies, EDBI and SEEDS Capital, to form a new entity next year, according to an announcement on Friday.
EDBI, the investment arm of Singapore’s Economic Development Board (EDB), and SEEDS C... |
| 02.08.2024 | UPS plan to sweeten holiday profits could turn off shippers | BusinessUPS plan to sweeten holiday profits could turn off shippers
By Lisa BaertleinAugust 2, 202410:33 AM UTCUpdated ago
Text
Small Text
Medium Text
Large Text
Share
X
Facebook
Linkedin
Email
Link
A UPS logo is seen on the side of a deliv... |
| 30.07.2024 | CVS Health Faces Legal Storm as Investors Seek Justice | CVS Health Corporation is in the eye of a legal hurricane. Investors are rallying, ready to take a stand against what they claim is a web of deception spun by the company. The stakes are high, and the clock is ticking.
A class action lawsui... |
| 29.07.2024 | New push for mRNA bird flu vaccine development: WHO | GENEVA: The World Health Organization announced on Monday (Jul 29) a new project to accelerate the development in poorer countries of vaccines for human bird flu infections using cutting-edge messenger RNA technology.
The WHO said Argentini... |
| 29.07.2024 | RSV vaccine makers vying for market share in second year of shots | Healthcare & PharmaceuticalsHealthcare Providers
RSV vaccine makers vying for market share in second year of shots
By Michael ErmanJuly 29, 20242:27 PM UTCUpdated ago
Text
Small Text
Medium Text
Large Text
Share
X
Facebook
Linkedin
Emai... |
| 27.07.2024 | Navigating the AI Landscape: Compliance, Challenges, and Opportunities | Artificial Intelligence (AI) is no longer a futuristic concept. It’s here, shaping industries and redefining how we work. Yet, as organizations rush to adopt AI, they face a maze of challenges. Two recent reports shed light on this evolving... |
| 27.07.2024 | Navigating the New Frontier of AI Compliance and Cyber Resilience | The digital landscape is shifting. Companies are scrambling to adapt. OpenAI and Commvault are leading the charge, unveiling tools and strategies to tackle compliance and cyber threats. Their recent announcements signal a pivotal moment in ... |
| 25.07.2024 | The Bird Flu Dilemma: A Call for Action in the U.S. Dairy Industry**
** | ** The bird flu is knocking at the door of the U.S. dairy industry. It’s a silent threat, creeping in with the stealth of a shadow. Colorado is ground zero, grappling with an outbreak that has already claimed millions of chickens and raised... |
| 22.07.2024 | Finland is offering farmworkers bird flu shots. Some experts say the US should, too | “Now is the time to offer the vaccines to farmworkers in the United States,” said Nahid Bhadelia, director of the Boston University Center on Emerging Infectious Diseases. Even more urgent measures are lagging in the U.S., she added. Testin... |
| 21.07.2024 | OpenAI добавила инструменты для комплаенса и администрирования в ChatGPT Enterprise | OpenAI представила несколько новых инструментов и функций для клиентов ChatGPT Enterprise, которые помогут им соблюдать правила соответствия, безопасности данных и управления ими. Они включают интеграцию API соответствия, систему междоменно... |
| 19.07.2024 | Dr. Richard Feldman: Society needs to be on guard for next pandemic | - |
| 10.07.2024 | Flagship Pioneering Raises $3.6 Billion to Fuel Breakthrough Innovations that Transform Human Health and Sustainability | Record Year with Key Partnerships, Global Expansion and Expanded Top Talent
CAMBRIDGE, Mass., July 10, 2024 /PRNewswire/ -- Flagship Pioneering, the bioplatform innovation company, today announced it has expanded its capital base by $3.6 bi... |
| 10.07.2024 | Antonin (Tony) de Fougerolles appointed as new Chair of etherna | Brings foundational experience in mRNA and LNP therapeutics given prior executive leadership roles at Moderna & Alnylam
Will take an active role in expanding partnerships with biopharma
Integrated partnership offering to customers remai... |
| 10.07.2024 | Flagship Pioneering Expands Leadership Team with Key Appointments and Promotions | CAMBRIDGE, Mass., July 10, 2024 /PRNewswire/ -- Flagship Pioneering, the bioplatform innovation company, today announced additions to its leadership team through key executive appointments and promotions. Today's personnel announcement acco... |
| 10.07.2024 | Former FBI Boston Field Office Special Agent in Charge Named to RaySecur Board of Advisors | Joseph Bonavolonta Joins Leading Mail Security Tech Company
BOSTON, July 10, 2024 /PRNewswire/ -- Today, RaySecur, the leading provider of T-ray security imaging technology, announced the appointment of Joseph (Joe) Bonavolonta to its advis... |
| 04.07.2024 | Dairy Cows: 4th Bird Flu Infection Case Found in Colorado | By Isaiah Richard
Published Jul 4, 2024 12:13AM EDT
Share on Facebook Share on Twitter Share on LinkedIn Share on Reddit Share on Flipboard Share on Pocket
A new bird flu virus infection found in Colorado was attributed to dairy cows, makin... |
| 02.07.2024 | US awards Moderna US$176 million to produce bird flu vaccine | The US government has awarded US$176 million to Moderna to advance development of its bird flu vaccine, the company said on Tuesday (Jul 2), as concerns rise over a multi-state outbreak of H5N1 virus in dairy cows and infections of three da... |
| 01.07.2024 | Scientists wary of bird flu pandemic 'unfolding in slow motion' | CHICAGO: Scientists tracking the spread of bird flu are increasingly concerned that gaps in surveillance may keep them several steps behind a new pandemic, according to Reuters interviews with more than a dozen leading disease experts.
Many... |
| 26.06.2024 | Circio invited to present circVec circular RNA technology at upcoming international RNA therapeutics conferences | Circio invited to present circVec circular RNA technology at upcoming international RNA therapeutics conferences
Wed, Jun 26, 2024 07:00 CET Report this content
Oslo, Norway 26 June 2024 – Circio Holding ASA (OSE: CRNA), a biotechnology com... |
| 19.06.2024 | Kong Names Joe Eskenazi Chief Revenue Officer | Kong Inc., a leading developer of cloud API technologies, today welcomed Joe Eskenazi as Chief Revenue Officer. Eskenazi will oversee Kong’s global sales organization, including Direct Sales, Sales Engineering, Sales and Business Developmen... |
| 19.06.2024 | ElevateBio: компания по производству генетических лекарств | Содержание
История компании
Технологии: объединение производства и некстген технологий терапевтического производства
Экосистема компании
BaseCamp
Партнеры
Отраслевые партнерства
Академические партнерства
Привлечение инвестиций История компа... |
| 18.06.2024 | Clover Announces Positive Preliminary Phase Ⅰ Results for Bivalent RSV Vaccine Candidate SCB-1019 in Older Adults | -- Bivalent SCB-1019 significantly boosted RSV-A and RSV-B neutralizing antibody titers in older adults up to approximately 7,900 IU/mL (up to 8-fold increase) and approximately 46,700 IU/mL (up to 11-fold increase), respectively --
-- Favo... |
| 18.06.2024 | Clover Announces Positive Preliminary Phase Ⅰ Results for Bivalent RSV Vaccine Candidate SCB-1019 in Older Adults | -- Bivalent SCB-1019 significantly boosted RSV-A and RSV-B neutralizing antibody titers in older adults up to approximately 7,900 IU/mL (up to 8-fold increase) and approximately 46,700 IU/mL (up to 11-fold increase), respectively --
-- Favo... |
| 13.06.2024 | AstraZeneca достигнет дохода $80 млрд к 2030 году | Компания AstraZeneca, крупнейший британский производитель лекарств, поставила перед собой смелую цель — к 2030 году достичь дохода в $80 млрд от продаж лекарств для лечения рака, редких заболеваний и других болезней, выпустив 20 новых крупн... |
| 11.06.2024 | Health | Another COVID vaccine? Yes, and here’s why | Last Wednesday, FDA’s advisers, a panel of physicians from hospitals and universities around the nation, unanimously voted to recommend a new vaccine. Vaccine manufacturers Pfizer and Moderna say they were prepared to make updated vaccines ... |
| 10.06.2024 | Moderna COVID-19/flu combo vaccine superior to separate shots in trial | Moderna said on Monday (Jun 10) that its combination vaccine to protect against both COVID-19 and influenza generated a stronger immune response in adults aged 50 and over when compared to separate shots against the viruses in a late-stage ... |
| 07.06.2024 | FDA approves first RSV vaccine for at-risk adults in their 50s | The Food and Drug Administration has approved giving GSK's vaccine for respiratory syncytial virus down to age 50 years old, to those who are at higher risk of severe RSV, the company said Friday, making it the first shot greenlit for use i... |
| 07.06.2024 | Simpplr Welcomes Marketing Powerhouse Gary Sevounts as Chief Marketing Officer | Simpplr.com
Simpplr proudly welcomes seasoned marketer Gary Sevounts as its new Chief Marketing Officer (CMO).
Sevounts' Proven Expertise In High-Growth Strategies and Category Building Will Amplify Simpplr's Market Leadership
REDWOOD CITY,... |
| 07.06.2024 | New COVID variant KP.3 climbs to 25%, now largest in CDC estimates | The new KP.3 variant has climbed to 1 in 4 new COVID-19 cases nationwide, the Centers for Disease Control and Prevention estimated Friday, making it now the dominant strain of the virus nationwide.
KP.3's ascent comes as the CDC has tracked... |
| 06.06.2024 | Updated COVID-19 vaccine in coming months should target variants with JN.1 lineage, say US advisers | Advisers to the US Food and Drug Administration on Wednesday (Jun 5) unanimously voted in favour of recommending that COVID-19 vaccines for 2024-25 should target a strain within the lineage of the JN.1 variant that has been dominant this ye... |
| 02.06.2024 | WHO members approve steps to bolster health regulations for pandemics | - |
| 31.05.2024 | Heatwave spurs surge in 'eye stroke' cases: What it is & how to stay safe | - |
| 31.05.2024 | FDA Roundup: May 31, 2024 | SILVER SPRING, Md., May 31, 2024 /PRNewswire/ -- Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:
Today, the FDA approved mRESVIA (Respiratory Syncytial Virus Vaccine) for the ... |
| 31.05.2024 | Moderna's RSV vaccine for older adults approved | figcaption>span]:font-sans">
Moderna's RSV shot for adults 60 and older was approved by the Food and Drug Administration on Friday, joining a growing group of vaccines protecting against the major respiratory threat.
Why it matte... |
| 30.05.2024 | US govt nears deal to fund late-stage trial of Moderna's bird flu vaccine | - |
| 25.05.2024 | Efforts to draft pandemic treaty falter as countries disagree on steps | - |
| 23.05.2024 | Эти компании процветали во время пандемии. Что с ними сейчас? | На прошлой неделе в заголовки новостей попали Zoom, DocuSign и Peloton — будто сейчас 2020 год, и пандемия в самом разгаре. Однако в отличие от тех времен новости в основном негативные. Рост доходов Zoom замедлился до 3% год к году. В 2023 ... |
| 17.05.2024 | Silver outlook: Prices may correct on hawkish Fedspeak, elevated inflation | - |
| 10.05.2024 | Nations struggle to draft pandemic treaty to avoid mistakes made in Covid | - |
| 10.05.2024 | Novavax strikes $1.2 billion deal with Sanofi in major turnaround | figcaption>span]:font-sans">
The French drug giant Sanofi is taking a minority stake in Novavax and entering into a licensing agreement worth as much as $1.2 billion that includes selling a combination COVID-flu shot.
Why it matt... |
| 10.05.2024 | "FLiRT" COVID variants are now more than a third of U.S. cases. Scientists share what we know about them so far. | More than a third of COVID-19 cases in the U.S. are now estimated to be from a new, fast-growing member of a group of so-called "FLiRT" variants, nicknamed for their small but distinctive changes relative to the JN.1 strain. JN.1 ... |
| 10.05.2024 | US drug regulator delaying decision on RSV vaccine approval, says Moderna | - |
| 09.05.2024 | Covishield side effects: Doctors' group urges to review all Covid vaccines | - |
| 08.05.2024 | AstraZeneca Withdraws Covid Vaccine After 3 Billion Shots Administered — But Why? | John Lopez, Tech Times 08 May 2024, 10:05 am
AstraZeneca has recently announced the withdrawal of its Covid-19 vaccine. This vaccine has been used widely worldwide, with over three billion doses administered so far.
The European Medicines A... |
| 01.05.2024 | Moderna and OpenAI collaborate to advance mRNA medicine | - |
| 01.05.2024 | Moderna and OpenAI collaborate to advance mRNA medicine | Moderna, Inc.
Moderna and OpenAI collaborate to advance mRNA medicine
……
This document is a Japanese translation of an announcement made by Moderna (Cambridge, Massachusetts) on April 24, 2024 (local time), and is provided to members of the... |
| 30.04.2024 | Exclusive: VP candidate Nicole Shanahan kicks off media campaign | figcaption>span]:font-sans">
Nicole Shanahan, the vice presidential candidate running alongside Robert F. Kennedy Jr. on his independent presidential ticket, is launching a podcast and social media push as part of a broader media... |
| 30.04.2024 | AstraZeneca vaccine: From its origin to side effects, all you need to know | - |
| 24.04.2024 | График вакцинопрофанации | - |
| 17.04.2024 | Путин: в мире высок риск возникновения новых эпидемий, особенно уязвима Африка | - |
| 16.04.2024 | Biden govt announces partnership with 50 nations to stifle future pandemics | - |
| 15.04.2024 | Inflation could hamper 'soft landing' of global economy despite US growth | - |
| 11.04.2024 | Long-Term Impact: Two-Thirds of Severe COVID Survivors Struggle Year After Infection | Quincy Jon, Tech Times 11 April 2024, 12:04 pm
A new study reveals that COVID-19 survivors generally struggle to recover completely. Researchers found that two-thirds of severe COVID patients have physical, mental, and cognitive difficultie... |
| 08.04.2024 | Clover Announces Positive Preliminary Phase I Results for Bivalent RSV Vaccine Candidate SCB-1019 in Initial Young Adult Cohort | -- Bivalent SCB-1019 significantly boosted RSV-A and RSV-B neutralization titers to approximately 6,600 IU/mL (6.4-fold increase) and approximately 46,000 IU/mL (12-fold increase), respectively --
-- Preliminary Phase I data in target older... |
| 04.04.2024 | Don't count us out yet, Novavax says | After losing out on the COVID-19 vaccine race, Novavax is hoping its experimental combo flu-COVID vaccine can help turn around its fortunes.
But it finds itself in a familiar position of playing catch-up.
Why it matters: A year after it war... |
| 18.03.2024 | Pandemic pact crunch time: Final treaty talks start to prevent future deaths | An international draft treaty aimed at bolstering readiness for the next pandemic enters a final round of scheduled negotiations Monday, with key disagreements remaining about how much knowledge and product drugmakers must share with the wo... |
| 16.03.2024 | COVID paved the way for a new vaccine era | The unprecedented success of the COVID-19 vaccines has elevated the mRNA platform and raised expectations the technology could soon be wielded against other infectious diseases.
The big picture: COVID is still the only disease for which any... |
| 11.03.2024 | CytomX Therapeutics Reports 2023 Financial Results and Provides Business Update | - CX-904 (EGFRxCD3 T-cell engager) initial Phase 1a dose escalation data in solid tumors anticipated in the 2nd half of 2024 -
- CX-2051 (EpCAM ADC) Phase 1 clinical study initiation in solid tumors, including colorectal cancer (CRC) antici... |
| 06.03.2024 | Moderna Japan displays prize flag at Sumo Tournament March venue | Moderna, Inc.
Moderna Japan displays prize flag at Sumo Tournament March venue ……
Moderna Japan Co., Ltd. (hereinafter referred to as “Moderna Japan”), the Japanese subsidiary of Moderna Inc. (hereinafter referred to as “Moderna”), will hol... |
| 06.02.2024 | Moderna named one of Fortune Magazine’s “World’s Most Admired Companies” | - |
| 06.02.2024 | Moderna named one of Fortune Magazine’s “World’s Most Admired Companies” | Moderna, Inc.
Moderna named one of Fortune Magazine’s “World’s Most Admired Companies” ……
This document is a Japanese translation of an announcement by Moderna (Cambridge, Massachusetts) on January 31, 2024 (local time), and is provided to ... |
| 25.10.2023 | モデルナ、「スパイクバックス®筋注」において、生後6カ月以上を対象とした初回免疫に関する一部変更承認を取得 | Moderna Inc.（以下、「モデルナ」）の日本法人モデルナ・ジャパン株式会社（東京都港区、以下、「モデルナ・ジャパン」）は10月24日付で「スパイクバックス®筋注」における、生後6カ月以上を対象とした初回免疫に関する承認事項の一部変更承認を取得したことをお知らせします。ただし、厚生科学審議会への諮問・答申を経て、予防接種実施規則改正をもってはじめて特例臨時接種での使用が可能となります。特例臨時接種としては現時点で初回免疫に対する接種はできません。
2023年秋以降の接... |
| 11.10.2023 | モデルナ、インフルエンザとCOVID-19の混合ワクチンmRNA-1083の第1/2相臨床試験の良好なデータを発表 | この資料は、モデルナ（マサチューセッツ州ケンブリッジ）が2023年10月4日（現地時間）に発表したものを日本語に翻訳したもので、報道関係者の皆さまに参考資料として提供するものです。資料の内容および解釈については、英語が優先されます。英語版は、https://www.modernatx.comをご参照下さい。
mRNA-1083は、承認されている単独ワクチンと比較して、インフルエンザとCOVID-19に対して強い免疫原性および、許容可能な反応原性および安全性プロファイルを示す... |
| 10.10.2023 | モデルナ、がん、希少疾患、感染症にわたる良好な臨床結果により、mRNA医薬品領域を拡大 | この資料は、モデルナ（マサチューセッツ州ケンブリッジ）が2023年9月13日（現地時間）に発表したものを日本語に翻訳したもので、報道関係者の皆さまに参考資料として提供するものです。資料の内容および解釈については、英語が優先されます。英語版は、https://www.modernatx.comをご参照下さい。
モデルナのインフルエンザワクチンmRNA-1010は、第３相臨床試験で主要評価項目を達成。別の第1/2相臨床試験では、インフルエンザワクチンFluzone HDよりも高... |
| 11.09.2023 | Moderna and Immatics jointly develop innovative oncology therapeutics | Moderna, Inc. and Immatics N.V. enter into a multi-billion dollar strategic research and development collaboration to jointly develop novel and transformative therapies for cancer patients with high unmet medical needs. Both biotechnology c... |
| 29.04.2023 | Moderna's billionaire CEO draws criticism for earning nearly $400 million in stock options last year, and then getting a raise on top of it | Moderna CEO Stéphane Bancel joined the firm in 2011 before its rise to the top of the pharmaceutical industry. Chip Somodevilla/Getty
Redeem now
French businessman Stéphane Bancel made $393 million in stock options in 2022, according to sec... |
| 20.04.2023 | IBM and Moderna explore quantum computing and generative AI with new partnership | Join top executives in San Francisco on July 11-12, to hear how leaders are integrating and optimizing AI investments for success. Learn More
The scientific miracle that is mRNA vaccines could be advanced even further in the coming years, t... |
| 20.04.2023 | Moderna partners with IBM to speed up mRNA vaccine development | The company will gain access to IBM's quantum and artificial intelligence technology
The COVID-19 vaccine was the fastest ever created, taking less than 12 months from identifying SARS-CoV-2 to discovering an immune response against it to d... |
| 16.04.2023 | Moderna and Merck Announce mRNA-4157 (V940), an Investigational Individualized Neoantigen Therapy, in Combination with KEYTRUDA(R) (Pembrolizumab), Demonstrated Superior Recurrence-Free Survival in Pa... | mRNA-4157 (V940) in combination with KEYTRUDA reduced the risk of recurrence or death by 44% compared to KEYTRUDA alone in stage III/IV melanoma patients with high risk of recurrence following complete resection
Results from the Phase 2b KE... |
| 14.03.2023 | Moderna Announces Phase 2 Data on mRNA-4157/V940, an Investigational mRNA Personalized Cancer Vaccine, to be Presented at the 2023 AACR Annual Meeting | CAMBRIDGE, MA / ACCESSWIRE / March 14, 2023 / Moderna, Inc. MRNA, a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that two abstracts on mRNA-4157/V940 an investigational mRNA personalized c... |
| 22.02.2023 | Moderna and Merck Announce mRNA-4157/V940, an Investigational Personalized mRNA Cancer Vaccine, in Combination With KEYTRUDA(R) (pembrolizumab), was Granted Breakthrough Therapy Designation by the FDA... | Designation based on positive data from Phase 2b KEYNOTE-942/mRNA-4157-P201 trial
CAMBRIDGE, MA and RAHWAY, NJ / ACCESSWIRE / February 22, 2023 / Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeut... |
| 16.02.2023 | Moderna Will Offer Free COVID Shots to Uninsured After Emergency Ends | THURSDAY, Feb. 16, 2023 (HealthDay News) -- American adults who have no health insurance or those who are underinsured will still be able to get free COVID vaccines from Moderna, even after government-purchased supplies run out, the company... |
| 09.01.2023 | COVID-19 vaccines: From nasal drops to a redesign, what 2023 could have in store | Several vaccine companies say they are expecting breakthroughs as early as this year as they pursue new ways to protect people against SARS-CoV-2, the virus that causes COVID-19.
The Food and Drug Administration is set to convene a panel of... |
| 05.01.2023 | Moderna and CytomX Announce Strategic Research Collaboration for mRNA-Based Conditionally Activated Therapeutics | Collaboration will combine Moderna's mRNA technology with CytomX's Probody® Platform to generate and develop therapeutics for oncology and non-oncology conditions
CytomX to receive $35 million upfront payment with the potential for addition... |
| 08.12.2022 | Moderna Receives FDA Emergency Use Authorization for Omicron-Targeting Bivalent COVID-19 Booster Vaccine in Children 6 Months Through 5 Years of Age | mRNA-1273.222 Targets the BA.4/BA.5 Strains of Omicron Variant
Authorization Is Based Upon Clinical and Pre-Clinical Data for Moderna's Bivalent Vaccines
CAMBRIDGE, MA / ACCESSWIRE / December 8, 2022 / Moderna, Inc. (NASDAQ:MRNA), a biotech... |
| 16.11.2022 | Moderna Tops BioSpace's Best Places to Work Ranking for Second Consecutive Year | CAMBRIDGE, MA / ACCESSWIRE / November 16, 2022 / Moderna, Inc., (NASDAQ:MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced it was ranked the number one large employer in BioSpace's 2023 ... |
